NDC 0074-9189
Trilipix
Fenofibric Acid
Trilipix is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Fenofibric Acid.
| Product ID | 0074-9189_5ba21517-084d-2b89-eaa9-d53a00f9c95f |
| NDC | 0074-9189 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Trilipix |
| Generic Name | Fenofibric Acid |
| Dosage Form | Capsule, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-12-15 |
| Marketing Category | NDA / DRUG FOR FURTHER PROCESSING |
| Application Number | NDA022224 |
| Labeler Name | AbbVie Inc. |
| Substance Name | FENOFIBRIC ACID |
| Active Ingredient Strength | 135 mg/1 |
| Pharm Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0074-9189-90
90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0074-9189-90)
| Marketing Start Date | 2008-12-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0074-9189-90 [00074918990]
Trilipix CAPSULE, DELAYED RELEASE
| Marketing Category | NDA |
| Application Number | NDA022224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-12-15 |
NDC 0074-9189-30 [00074918930]
Trilipix CAPSULE, DELAYED RELEASE
| Marketing Category | NDA |
| Application Number | NDA022224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-10-11 |
| Marketing End Date | 2012-09-13 |
NDC 0074-9189-07 [00074918907]
Trilipix CAPSULE, DELAYED RELEASE
| Marketing Category | NDA |
| Application Number | NDA022224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2008-12-15 |
| Marketing End Date | 2016-05-06 |
NDC 0074-9189-10 [00074918910]
Trilipix CAPSULE, DELAYED RELEASE
| Marketing Category | NDA |
| Application Number | NDA022224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-09-13 |
| Marketing End Date | 2014-11-06 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| FENOFIBRIC ACID | 135 mg/1 |
NDC Crossover Matching brand name "Trilipix" or generic name "Fenofibric Acid"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0074-3161 | Trilipix | Fenofibric Acid |
| 0074-3162 | Trilipix | Fenofibric Acid |
| 0074-9189 | Trilipix | Fenofibric Acid |
| 0074-9642 | Trilipix | Fenofibric Acid |
| 0115-1554 | Fenofibric Acid | Fenofibric Acid |
| 0115-1555 | Fenofibric Acid | Fenofibric Acid |
| 0228-2838 | fenofibric acid | fenofibric acid |
| 0228-2839 | fenofibric acid | fenofibric acid |
| 0378-2589 | Fenofibric Acid | fenofibric acid |
| 0378-2590 | Fenofibric Acid | fenofibric acid |
| 10370-209 | Fenofibric Acid | Fenofibric Acid |
| 10370-210 | Fenofibric Acid | Fenofibric Acid |
| 24979-109 | Fenofibric Acid | Fenofibric Acid |
| 24979-112 | Fenofibric Acid | Fenofibric Acid |
| 42385-944 | FENOFIBRIC ACID DELAYED-RELEASE | FENOFIBRIC ACID |
| 42385-945 | FENOFIBRIC ACID DELAYED-RELEASE | Fenofibric Acid |
| 13310-101 | FIBRICOR | Fenofibric Acid |
| 13310-102 | FIBRICOR | Fenofibric Acid |
Trademark Results [Trilipix]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TRILIPIX 78243528 not registered Dead/Abandoned |
Abbott Laboratories 2003-04-29 |
 TRILIPIX 77116366 3587733 Live/Registered |
ABBVIE INC. 2007-02-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.